New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists
-
* Corresponding author: Hetty Carraway hcarraw1@jhmi.edu
Breast Cancer Res 2004, 6:219-224 doi:10.1186/bcr927
Accesses
- Last 30 days: 57 accesses
- Last year: 1031 accesses
- All time: 9840 accesses
Cited by
BioMed Central: 2 citations
|
Review
John P Alao Molecular Cancer 2007, 6:24 (2 April 2007) |
|
Viewpoint
Determining sensitivity to rapamycin and its analogues in breast cancer patients Caroline J Witton Breast Cancer Res 2005, 7:41-42 (17 December 2004) |
